Impaired tax-specific t-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages

Cancer Science

Volumn 100, Issue 3, 2009, Pages 481-489

  Shimizu, Yukiko ^a   Takamori, Ayako ^a   Utsunomiya, Atae ^b   Kurimura, Mayumi ^c   Yamano, Yoshihisa ^d   Hishizawa, Masakatsu ^e   Hasegawa, Atsuhiko ^a   Kondo, Fumiaki ^a   Kurihara, Kiyoshi ^a   Harashima, Nanae ^a   Watanabe, Toshiki ^f   Okamura, Jun ^g   Masuda, Takao ^a   Kannagi, Mari ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b IMAMURA BUN IN HOSPITAL   (Japan)

^c Kamigotoh Hospital   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; PROTEIN P19; TAX PROTEIN; CCR4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; T CELL LEUKEMIA; VIRUS LOAD; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOSURVEILLANCE; METABOLISM; MIDDLE AGED; VIROLOGY;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOLOGIC SURVEILLANCE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; RECEPTORS, CCR4; T-LYMPHOCYTES, CYTOTOXIC;

EID: 62849126897     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.01054.x     Document Type: Article

References (46)

1. Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-80.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-19.
3. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia. clinical and hematologic features of 16 cases. Blood 1977; 50: 481-92.
4. Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 1990; 45: 237-43.
5. Arisawa K, Soda M, Endo S et al. Evaluation of adult T-cell leukemia/ lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 2000; 85: 319-24.
6. Gessain A, Barin F, Vernant JC et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407-10.
7. Osame M, Usuku K, Izumo S et al. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031-2.
8. Hisada M, Okayama A, Spiegelman D, Mueller NE, Stuver SO. Sex-specific mortality from adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Int J Cancer 2001; 91: 497-9.
9. Hisada M, Okayama A, Tachibana N et al. Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan. Int J Cancer 1998; 77: 188-92.
10. Okayama A, Stuver S, Matsuoka M et al. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 2004; 110: 621-5.
11. Nagai M, Usuku K, Matsumoto W et al. Analysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: High proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4: 586-93.
12. Ishida T, Utsunomiya A, Iida S et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: Its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003; 9: 3625-34.
13. Yoshie O, Fujisawa R, Nakayama T et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002; 99: 1505-11.
14. Karube K, Ohshima K, Tsuchiya T et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/ lymphoma cells. Br J Haematol 2004; 126: 81-4.
15. Matsubara Y, Hori T, Morita R, Sakaguchi S, Uchiyama T. Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells. Leukemia 2005; 19: 482-3.
16. Kohno T, Yamada Y, Akamatsu N et al. Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci 2005; 96: 527-33.
17. + regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18-32.
18. + T lymphocytes with regulatory activity. J Immunol 2001; 166: 996-1002.
19. Iellem A, Mariani M, Lang R et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4 (+) CD25 (+) regulatory T cells. J Exp Med 2001; 194: 847-53.
20. + suppressor T cells: More questions than answers. Nat Rev Immunol 2002; 2: 389-400.
21. + adult T cell leukemia cells. Int Immunol 2006; 18: 269-77.
22. Katsuki T, Katsuki K, Imai J, Hinuma Y. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-1). impairment of T-cell control of Epstein-Barr virus-infected B-cells. Jpn J Cancer Res 1987; 78: 639-42.
23. Nakada K, Yamaguchi K, Furugen S et al. Monoclonal integration of HTLV-1 proviral DNA in patients with strongyloidiasis. Int J Cancer 1987; 40: 145-8.
24. + cytotoxic T lymphocytes specific for HTLV-1 pX in patients with HTLV-1 associated neurological disease. Nature 1990; 348: 245-8.
25. Kannagi M, Sugamura K, Kinoshita K, Uchino H, Hinuma Y. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. J Immunol 1984; 133: 1037-41.
26. + T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/ lymphoma. Leukemia 2004; 18: 126-32.
27. Bangham CR, Osame M. Cellular immune response to HTLV-1. Oncogene 2005; 24: 6035-46.
28. + cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J General Virol 2005; 86: 1515-23.
29. Harashima N, Kurihara K, Utsunomiya A et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 2004; 64: 391-9.
30. Hasegawa A, Ohashi T, Hanabuchi S et al. Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response. J Virol 2003; 77: 2956-63.
31. Komori K, Hasegawa A, Kurihara K et al. Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells. J Virol 2006; 80: 7375-81.
32. Ohashi T, Hanabuchi S, Kato H et al. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine. J Virol 2000; 74: 9610-6.
33. Hanabuchi S, Ohashi T, Koya Y et al. Regression of human T-cell leukemia virus type I (HTLV-1)-associated lymphomas in a rat model: peptide-induced T-cell immunity. J Natl Cancer Inst 2001; 93: 1775-83.
34. Kannagi M, Sugamura K, Sato H, Okochi K, Uchino H, Hinuma Y. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells. J Immunol 1983; 130: 2942-6.
35. Parker CE, Daenke S, Nightingale S, Bangham CR. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188: 628-36.
36. Kurihara K, Shimizu Y, Takamori A et al. Human T-cell leukemia virus type-I (HTLV-1)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins. J Immunol Meth 2006; 313: 61-73.
37. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79: 428-37.
38. Yamaguchi K, Kiyokawa T, Nakada K et al. Polyclonal integration of HTLV-1 proviral DNA in lymphocytes from HTLV-1 seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL. Br J Haematol 1988; 68: 169-74.
39. Harashima N, Tanosaki R, Shimizu Y et al. Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation. J Virol 2005; 79: 10 088-92.
40. Sonoda J, Koriyama C, Yamamoto S et al. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci 2004; 95: 596-601.
41. Tanaka G, Okayama A, Watanabe T et al. The clonal expansion of human T lymphotropic virus type 1-infected T cells: A comparison between seroconverters and long-term carriers. J Infect Dis 2005; 191: 1140-7.
42. Itoyama Y, Minato S, Kira J et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-1-associated myelopathy. Neurology 1988; 38: 1302-7.
43. Jacobson S, Zaninovic V, Mora C et al. Immunological findings in neurological diseases associated with antibodies to HTLV-1: Activated lymphocytes in tropical spastic paraparesis. Ann Neurol 1988; 23 (Suppl): S196-200.
44. Kramer A, Jacobson S, Reuben JF et al. Spontaneous lymphocyte proliferation in symptom-free HTLV-1 positive Jamaicans. Lancet 1989; 2: 923-4.
45. + T cells. Blood 2001; 98: 1506-11.
46. Iwatsuki K, Harada H, Motoki Y, Kaneko F, Jin F, Takigawa M. Diversity of immunobiological functions of T-cell lines established from patients with adult T-cell leukaemia. Br J Dermatol 1995; 133: 861-7.